Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza
- PMID: 30443990
- PMCID: PMC6379630
- DOI: 10.1111/irv.12621
Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza
Abstract
Objective: This study evaluated the diagnostic value of measuring the levels of procalcitonin (PCT) and C-reactive protein (CRP) to differentiate children co-infected with H1N1 influenza and bacteria from children infected with H1N1 influenza alone.
Methods: Consecutive patients (children aged < 5 years) with laboratory-confirmed H1N1 influenza who were hospitalized or received outpatient care from a tertiary-care hospital in Canton, China, between January 1, 2012, and September 1, 2017, were included in the present study. Laboratory results, including serum PCT and CRP levels, white blood cell (WBC) counts, and bacterial cultures, were analyzed. The predictive value of the combination of biomarkers versus any of the biomarkers alone for diagnosing bacterial co-infections was evaluated using logistic regression analyses.
Results: Significantly higher PCT (1.46 vs 0.21 ng/mL, P < 0.001) and CRP (19.20 vs 5.10 mg/dL, P < 0.001) levels were detected in the bacterial co-infection group than in the H1N1 infection-alone group. Using PCT or CRP levels alone, the areas under the curves (AUCs) for predicting bacterial co-infections were 0.801 (95% CI, 0.772-0.855) and 0.762 (95% CI, 0.722-0.803), respectively. Using a combination of PCT and CRP, the logistic regression-based model, Logit(P) = -1.912 + 0.546 PCT + 0.087 CRP, showed significantly greater accuracy (AUC: 0.893, 95% CI: 0.842-0.934) than did the other three biomarkers.
Conclusions: The combination of PCT and CRP levels could provide a useful method of distinguishing bacterial co-infections from an H1N1 influenza infection alone in children during the early disease phase. After further validation, the flexible model derived here could assist clinicians in decision-making processes.
Keywords: C-reactive protein; H1N1 influenza; bacterial co-infection; procalcitonin.
© 2018 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Figures


Similar articles
-
Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.Intensive Care Med. 2010 Mar;36(3):528-32. doi: 10.1007/s00134-009-1746-3. Intensive Care Med. 2010. PMID: 20069274 Free PMC article.
-
Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia.Influenza Other Respir Viruses. 2011 Nov;5(6):398-403. doi: 10.1111/j.1750-2659.2011.00244.x. Epub 2011 Mar 30. Influenza Other Respir Viruses. 2011. PMID: 21668682 Free PMC article.
-
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.Clin Chem Lab Med. 2020 Nov 19;59(2):433-440. doi: 10.1515/cclm-2020-1361. Clin Chem Lab Med. 2020. PMID: 33554505
-
The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.Crit Care. 2018 Nov 21;22(1):316. doi: 10.1186/s13054-018-2236-1. Crit Care. 2018. PMID: 30463590 Free PMC article.
-
Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.Ren Fail. 2022 Dec;44(1):81-93. doi: 10.1080/0886022X.2021.2021236. Ren Fail. 2022. PMID: 35164633 Free PMC article.
Cited by
-
Rapid Diagnostic Tests to Guide Case Management of and Improve Antibiotic Stewardship for Pediatric Acute Respiratory Illnesses in Resource-Constrained Settings: a Prospective Cohort Study in Southwestern Uganda.Microbiol Spectr. 2021 Dec 22;9(3):e0169421. doi: 10.1128/Spectrum.01694-21. Epub 2021 Nov 24. Microbiol Spectr. 2021. PMID: 34817224 Free PMC article.
-
Low Levels of Procalcitonin Are Related to Decreased Antibiotic Use in Children Hospitalized Due to Influenza.Diagnostics (Basel). 2022 May 5;12(5):1148. doi: 10.3390/diagnostics12051148. Diagnostics (Basel). 2022. PMID: 35626302 Free PMC article.
-
Assessing Biomarkers in Viral Infection.Adv Exp Med Biol. 2023;1412:159-173. doi: 10.1007/978-3-031-28012-2_8. Adv Exp Med Biol. 2023. PMID: 37378766 Review.
-
Use of common blood parameters for the differential diagnosis of childhood infections.PLoS One. 2022 Sep 12;17(9):e0273236. doi: 10.1371/journal.pone.0273236. eCollection 2022. PLoS One. 2022. PMID: 36095013 Free PMC article.
-
NLRP6 Induces Lung Injury and Inflammation Early in Brucella and Influenza Coinfection.J Pers Med. 2022 Dec 14;12(12):2063. doi: 10.3390/jpm12122063. J Pers Med. 2022. PMID: 36556283 Free PMC article.
References
-
- Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta‐analysis. The Lancet. 2011;378:1917‐1930. - PubMed
-
- McCullers JA. The co‐pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:nrmicro3231. - PubMed
-
- Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Eng J Med. 2009;361:1935‐1944. - PubMed
-
- Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309:275‐282. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous